CLOV has an insider buy conviction of 9%, compared to the Unknown sector buy average of 6%.
Insider Trading Summary & Commentary
Automated executive transaction analysis for CLOV
Over the last 90 days, corporate insiders at CLOV (CLOV) engaged in a total of 98 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 53 were sales. The total volume of insider trading reached $12.03M.
The net insider activity for CLOV shows a net selling bias of $9.89M. This activity represents a 9% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.86M shares valued at $829.71B on Aug 7, 2025.
Live Market News & Developments
Aggregated real-time headlines for CLOV (CLOV)
6 updates
Clover Health Investments (CLOV) Pulls Back As The Medicare Advantage Narrative Still Points To Value
Simply Wall St2h ago
Clover Health (CLOV) Gets New ‘Buy’ Call, Higher PT, Climbs 8.5%
Yahoo Finance71d ago
Is Clover Health Stock Too Dependent On One Group Of Members?
Trefis42d ago
Clover Health Stock Pops: What's Happening?
Benzinga42d ago
Humana Drops 8.5% Intraday: What the Selloff Looks Like
24/7 Wall St.Yesterday
CLOV - Clover Health Investments Corp Stock Price and Quote
Finviz176d ago
FAQs About CLOV Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for CLOV.
Based on SEC Form 4 disclosures, the Insider Confidence Score for CLOV is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 2 purchases and 53 sales by company executives over the last 90 days.
The CEO Conviction Index for CLOV is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.
No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.